onyx shares up 21% on today's news.he next step it s to appeal to the food and drug administration. jessica, if the fda approves, they can sell it. >> okay. >> reporter: >> thank you, scott. >> reporter: you bet. >>> sensitive and classified field reports from afghanistan filed by u.s. forces during a five-year period have been leaked to the internet. there is anger about that security breach, and about the revelations of how u.s. allies are allegedly helping the taliban. as nbc bay area's steve handlesman explains, an anti-war online group is attacking u.s. policy and they are the culprit of the leak. >> reporter: made public for classified intelligence and action reports, filed by u.s. forces in afghanistan from '04 to '09. troops worried about local support, worried about civilian deaths. 90,000 reports like these four released online by wikileaks.org. >> it's war. it's one damn thing after another. >> reporter: wikileaks founder julian asange claims u.s. involvement sill legal. >> it does appear to be evidence of wa

this optimism was a shot in the arm for onyx shareholders. the stock jumped 21% on more 10 times its normal volume. this stock was at a 52-week low earlier this month. this experimental treatment for multiple myeloma is the firm's lead drug in development. it wasn't the only biotech stock jumping, genzyme saw follow- through buying from friday on more buyout chatter. if genzyme is on any company's buy list, it keeps getting more expensive. shares were around $54 friday morning, tonight they're above $67, a 24% return in two sessions. here's the one-year on genzyme, clearly at a new 52-week high. the buyout talk first centered around sanofi-aventis as an interested party, but analysts also speculate genzyme would fit in at glaxosmithkline and johnson & johnson. for sanofi, five of its eight best-selling will have generic competitors within two years. the "wall street journal" reports glaxo has expressed interest in genzyme. of the three, johnson & johnson has the most cash on its balance sheet, about $18 billion. those better-than-expected new

. >> and another question, that what do think of onyx pharmaceuticals?> and i forwarded you this article. >> you gave this a way. >> this is the bay area company with a cancer drug. and their stock shot up and when you read it? perhaps it is too late. >> this is phase two for cancer and it is towards melanoma. and it is a bullet shot into cancer. and i do not even know what type of cancer that is. people like me, financial people and money talk about biotech companies would do not know we're talking about. and i'm not a scientist, i do not pretend to be a scientist. and if i would say that the biotech's most difficult to choose. usually, the entire index or mutual-fund of biotech. and perhaps hair loss law for law, or a cure for, and if they thought like perhaps as td [laughter]? >> and roy >> and also, the risk that the fda approval. and the no on the approval, pond as far as the stock goes. >> and they do not have any product to offset revenue. so vague will hit a huge home run and when they have a strike out? cages plea pretty bad. >> thank you, and-i

among the hottest stocks today, a silicon valley biotech, onyx pharmaceutical saw its value jump more than 20%. the company's drug to fight a certain type of cancer came back with positive test results. up next, an appoint m with the fda. we'll hear from them at 6:00. >>> and google with the government seal of approval specifically the company's online applications like e-mail and word processing have now been certified as safe by the government to store and deliver information over the internet. tom google will likely use the new symbol to sell online programs to the government. another challenge to rival microsoft. >> scott, thank you. >>> iphone users who want to use software not approved by apple can now do it without fearing legal repercussions. the library of congress copyrite office ruled that it is legal to bypass the phone's controls to allow so called, jail breaking of phones and other devices. apple said it had the right to control the system but the library of congress says users can customize their phones as they see fit. a bay area company is issuing a recall of its humm

civil aviation to date were initially developed for military purposes and the same goes for every onyx. the military industry was leading the way and then it's to knowledge use were integrated into civil aviation but now the situation has changed due to a two way street on the one hand you have military technologies developed for military programs simply mounted in civil aviation but on the other hand many things in that had for civil aviation road for military planes for example boeing seven eighty seven on the it's use of compose of materials so it's a whole new level of aircraft design. so if we want to be a world leader in aircraft man. factory. booth is the military and civil sector. i know that you company plans to increase the share of civil aircraft because so far you make money mostly by making military aircraft and that do you plan to increase the share of civil aircraft by means of the russian market are you planning to promote your products more aggressively worldwide. there is no russian market in the aircraft industry there is the world market with you if we want to succe